Assessing Stereotactic Body Proton Therapy Treatment Plan Robustness to the Liver
To assess different proton beam arrangements’ robustness for planning stereotactic body proton therapy (SBPT) to the liver.
Poster Program · Therapy Physics
Author profile
The University of Texas MD Anderson Cancer Center
To assess different proton beam arrangements’ robustness for planning stereotactic body proton therapy (SBPT) to the liver.
Early body composition (BC) loss after chemotherapy associates with poor outcomes in PDAC, but its implications for treatment strategy remain unclear. Radiotherapy (RT) is sometimes considered after 6 months of chemotherapy for patients with unresectable dise...
The sensitivity of normal liver tissue raises concerns about potential liver function post-cancer treatment. We investigate whether liver radiomics features derived from standard CT-guided radiation therapy (RT) can improve acute functional liver decline pred...